mtt cell viability assay kit Search Results


mtt cell viability assay kit  (Biotium)
95
Biotium mtt cell viability assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Viability Assay Kit, supplied by Biotium, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell viability assay kit/product/Biotium
Average 95 stars, based on 1 article reviews
mtt cell viability assay kit - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
mtt cell proliferation assay kit  (Abnova)
90
Abnova mtt cell proliferation assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Proliferation Assay Kit, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell proliferation assay kit/product/Abnova
Average 90 stars, based on 1 article reviews
mtt cell proliferation assay kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cell quanti-mtt cell viability assay kit  (BioAssay Systems LLC)
90
BioAssay Systems LLC cell quanti-mtt cell viability assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Cell Quanti Mtt Cell Viability Assay Kit, supplied by BioAssay Systems LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell quanti-mtt cell viability assay kit/product/BioAssay Systems LLC
Average 90 stars, based on 1 article reviews
cell quanti-mtt cell viability assay kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mtt cell viability and proliferation assay kit  (ScienCell)
90
ScienCell mtt cell viability and proliferation assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Viability And Proliferation Assay Kit, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell viability and proliferation assay kit/product/ScienCell
Average 90 stars, based on 1 article reviews
mtt cell viability and proliferation assay kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mtt cell viability assay  (BioAssay Systems LLC)
90
BioAssay Systems LLC mtt cell viability assay
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Viability Assay, supplied by BioAssay Systems LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell viability assay/product/BioAssay Systems LLC
Average 90 stars, based on 1 article reviews
mtt cell viability assay - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cell viability kit for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (mtt) assay  (HiMedia Laboratories)
90
HiMedia Laboratories cell viability kit for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (mtt) assay
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Cell Viability Kit For 3 (4,5 Dimethylthiazol 2 Yl) 2,5 Diphenyl Tetrazolium Bromide (Mtt) Assay, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell viability kit for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (mtt) assay/product/HiMedia Laboratories
Average 90 stars, based on 1 article reviews
cell viability kit for 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (mtt) assay - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
3-(4,5-dimethylthiazol-2yl)2,5-diphenyltetrazolium bromide (mtt) kit  (Abnova)
90
Abnova 3-(4,5-dimethylthiazol-2yl)2,5-diphenyltetrazolium bromide (mtt) kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
3 (4,5 Dimethylthiazol 2yl)2,5 Diphenyltetrazolium Bromide (Mtt) Kit, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3-(4,5-dimethylthiazol-2yl)2,5-diphenyltetrazolium bromide (mtt) kit/product/Abnova
Average 90 stars, based on 1 article reviews
3-(4,5-dimethylthiazol-2yl)2,5-diphenyltetrazolium bromide (mtt) kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
(mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay  (Promega)
90
Promega (mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
(Mtt Viability Assay Kit, Celltiter 96 ® Aqueous Non Radioactive Cell Proliferation Assay, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/(mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay/product/Promega
Average 90 stars, based on 1 article reviews
(mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mtt cell viability assay kit ka1606  (Abnova)
90
Abnova mtt cell viability assay kit ka1606
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Viability Assay Kit Ka1606, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell viability assay kit ka1606/product/Abnova
Average 90 stars, based on 1 article reviews
mtt cell viability assay kit ka1606 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
colorimetric assay mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay  (Promega)
90
Promega colorimetric assay mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Colorimetric Assay Mtt Viability Assay Kit, Celltiter 96 ® Aqueous Non Radioactive Cell Proliferation Assay, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/colorimetric assay mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay/product/Promega
Average 90 stars, based on 1 article reviews
colorimetric assay mtt viability assay kit, celltiter 96 ® aqueous non-radioactive cell proliferation assay - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mtt solutions  (Ribobio co)
90
Ribobio co mtt solutions
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Solutions, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt solutions/product/Ribobio co
Average 90 stars, based on 1 article reviews
mtt solutions - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mtt aqueous one cell viability kit  (Promega)
90
Promega mtt aqueous one cell viability kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Aqueous One Cell Viability Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt aqueous one cell viability kit/product/Promega
Average 90 stars, based on 1 article reviews
mtt aqueous one cell viability kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and cell viability quantified by MTT assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.

Journal: Cancers

Article Title: Inhibition of Tumor Microenvironment Cytokine Signaling Sensitizes Ovarian Cancer Cells to Antiestrogen Therapy

doi: 10.3390/cancers14194675

Figure Lengend Snippet: Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and cell viability quantified by MTT assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.

Article Snippet: Cell viability was determined with the MTT Cell Viability Assay Kit (Biotium, Fremont, CA, USA, Cat. No.30006).

Techniques: MTT Assay, Inhibition, Colony Assay